Biocartis Group NV (EBR: BCART)
Belgium
· Delayed Price · Currency is EUR 0.290
0.00 (0.00%)
Nov 20, 2024, 9:00 AM CET
Biocartis Group NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 60.82 | 57.98 | 54.9 | 55.56 | 37.73 | 28.65 | Upgrade
|
| Revenue Growth (YoY) | 3.77% | 5.61% | -1.19% | 47.25% | 31.70% | 23.98% | Upgrade
|
| Cost of Revenue | 65.51 | 67.01 | 80.61 | 70.37 | 60.7 | 48.95 | Upgrade
|
| Gross Profit | -4.69 | -9.04 | -25.72 | -14.81 | -22.96 | -20.3 | Upgrade
|
| Selling, General & Admin | 37.32 | 36.83 | 32.32 | 30.35 | 32.16 | 23.32 | Upgrade
|
| Operating Expenses | 37.32 | 36.83 | 32.32 | 30.35 | 32.16 | 23.32 | Upgrade
|
| Operating Income | -42.01 | -45.87 | -58.04 | -45.16 | -55.13 | -43.62 | Upgrade
|
| Interest Expense | -16.09 | -11.19 | -9.32 | -10.18 | -7.1 | -1.36 | Upgrade
|
| Interest & Investment Income | 0 | - | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.83 | -0.88 | -0.66 | -0.53 | -0.63 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.8 | 0.8 | 1 | -1 | -0.1 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -8.73 | -7.3 | -0.09 | -0.28 | -0.74 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -66.86 | -64.44 | -67.11 | -57.16 | -63.69 | -45.02 | Upgrade
|
| Asset Writedown | -1.18 | -1.18 | -1.36 | -1.7 | -0.48 | -3.24 | Upgrade
|
| Other Unusual Items | - | - | -3.24 | -4.3 | - | - | Upgrade
|
| Pretax Income | -68.04 | -65.62 | -71.72 | -63.16 | -64.17 | -48.26 | Upgrade
|
| Income Tax Expense | -0.17 | -0.24 | -0.24 | -0.23 | -0.1 | -0.11 | Upgrade
|
| Earnings From Continuing Operations | -67.87 | -65.38 | -71.47 | -62.93 | -64.07 | -48.15 | Upgrade
|
| Net Income to Company | -67.87 | -65.38 | -71.47 | -62.93 | -64.07 | -48.15 | Upgrade
|
| Net Income | -67.87 | -65.38 | -71.47 | -62.93 | -64.07 | -48.15 | Upgrade
|
| Net Income to Common | -67.87 | -65.38 | -71.47 | -62.93 | -64.07 | -48.15 | Upgrade
|
| Shares Outstanding (Basic) | 78 | 61 | 58 | 57 | 56 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 78 | 61 | 58 | 57 | 56 | 51 | Upgrade
|
| Shares Change (YoY) | 36.22% | 5.21% | 1.65% | 0.96% | 9.58% | 13.34% | Upgrade
|
| EPS (Basic) | -0.87 | -1.08 | -1.24 | -1.11 | -1.14 | -0.94 | Upgrade
|
| EPS (Diluted) | -0.87 | -1.08 | -1.24 | -1.11 | -1.14 | -0.94 | Upgrade
|
| Free Cash Flow | -51.2 | -46.42 | -69.4 | -42.27 | -56.38 | -47.56 | Upgrade
|
| Free Cash Flow Per Share | -0.65 | -0.77 | -1.21 | -0.75 | -1.01 | -0.93 | Upgrade
|
| Gross Margin | -7.71% | -15.59% | -46.84% | -26.66% | -60.86% | -70.85% | Upgrade
|
| Operating Margin | -69.06% | -79.12% | -105.72% | -81.29% | -146.10% | -152.24% | Upgrade
|
| Profit Margin | -111.58% | -112.77% | -130.19% | -113.27% | -169.80% | -168.07% | Upgrade
|
| Free Cash Flow Margin | -84.18% | -80.07% | -126.42% | -76.08% | -149.41% | -166.01% | Upgrade
|
| EBITDA | -37.02 | -40.78 | -53.38 | -40.74 | -50.51 | -39.19 | Upgrade
|
| EBITDA Margin | -60.86% | -70.34% | -97.23% | -73.33% | -133.86% | -136.79% | Upgrade
|
| D&A For EBITDA | 4.99 | 5.09 | 4.66 | 4.42 | 4.62 | 4.43 | Upgrade
|
| EBIT | -42.01 | -45.87 | -58.04 | -45.16 | -55.13 | -43.62 | Upgrade
|
| EBIT Margin | -69.06% | -79.12% | -105.72% | -81.29% | -146.10% | -152.24% | Upgrade
|
| Revenue as Reported | 60.82 | 57.98 | 54.9 | 55.56 | 37.73 | 28.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.